Literature DB >> 7672026

The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task.

P M Grasby1, C D Frith, E Paulesu, K J Friston, R S Frackowiak, R J Dolan.   

Abstract

Scopolamine, a muscarinic antagonist, impairs memory performance in both humans and animals. In this study, repeated measurements of regional cerebral blood flow (rCBF) were made in normal volunteers whilst performing auditory verbal memory tasks, before and after the administration of scopolamine (0.4 mg s.c.) or placebo. Compared to placebo, scopolamine increased blood flow in the lateral occipital cortex bilaterally and the left orbitofrontal region. Scopolamine decreased rCBF in the region of the right thalamus, the precuneus and the right and left lateral premotor areas. Scopolamine attenuated memory-task-induced increases of rCBF in the left and right prefrontal cortex and the right anterior cingulate region. These data suggest that acute blockade of cholinergic neurotransmission affects diverse brain areas, including components of the visual and motor systems, and, in addition, modulates memory task activations at distinct points in a distributed network for memory function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672026     DOI: 10.1007/bf00242019

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  36 in total

1.  Measuring the neuromodulatory effects of drugs in man with positron emission tomography.

Authors:  K J Friston; P M Grasby; C J Bench; C D Frith; P J Cowen; P F Liddle; R S Frackowiak; R Dolan
Journal:  Neurosci Lett       Date:  1992-07-06       Impact factor: 3.046

Review 2.  The medial temporal lobe memory system.

Authors:  L R Squire; S Zola-Morgan
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

3.  Noninvasive functional brain mapping by change-distribution analysis of averaged PET images of H215O tissue activity.

Authors:  P T Fox; M A Mintun
Journal:  J Nucl Med       Date:  1989-02       Impact factor: 10.057

4.  Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.

Authors:  A A Bajalan; C E Wright; V J van der Vliet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

5.  Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.

Authors:  J Blin; C A Ray; M F Piercey; J J Bartko; M M Mouradian; T N Chase
Journal:  Brain Res       Date:  1994-01-28       Impact factor: 3.252

Review 6.  Localization of cognitive operations in the human brain.

Authors:  M I Posner; S E Petersen; P T Fox; M E Raichle
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

7.  Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man.

Authors:  J C Baron; R D'Antona; P Pantano; M Serdaru; Y Samson; M G Bousser
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

8.  Brain regions associated with acquisition and retrieval of verbal episodic memory.

Authors:  T Shallice; P Fletcher; C D Frith; P Grasby; R S Frackowiak; R J Dolan
Journal:  Nature       Date:  1994-04-14       Impact factor: 49.962

Review 9.  Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings.

Authors:  E Tulving; S Kapur; F I Craik; M Moscovitch; S Houle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

10.  Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.

Authors:  F P Bymaster; I Heath; J C Hendrix; H E Shannon
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

View more
  15 in total

1.  Functional MRI detection of pharmacologically induced memory impairment.

Authors:  Reisa Sperling; Douglas Greve; Anders Dale; Ronald Killiany; Jennifer Holmes; H Diana Rosas; Andrew Cocchiarella; Paul Firth; Bruce Rosen; Stephen Lake; Nicholas Lange; Carol Routledge; Marilyn Albert
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Cholinergic blockade under working memory demands encountered by increased rehearsal strategies: evidence from fMRI in healthy subjects.

Authors:  Bianca Voss; Renate Thienel; Martina Reske; Thilo Kellermann; Abigail J Sheldrick; Sarah Halfter; Katrin Radenbach; Nadim J Shah; Ute Habel; Tilo T J Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-10-18       Impact factor: 5.270

3.  The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.

Authors:  M Bahro; B G Schreurs; T Sunderland; S E Molchan
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  Prefrontal cortex HCN1 channels enable intrinsic persistent neural firing and executive memory function.

Authors:  Sébastien J Thuault; Gaël Malleret; Christine M Constantinople; Russell Nicholls; Irene Chen; Judy Zhu; Andrey Panteleyev; Svetlana Vronskaya; Matthew F Nolan; Randy Bruno; Steven A Siegelbaum; Eric R Kandel
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

Review 5.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

Review 6.  [Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].

Authors:  D Roesch-Ely; U Pfueller; C Mundt; U Müller; M Weisbrod
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

Review 7.  Modes and models of forebrain cholinergic neuromodulation of cognition.

Authors:  Michael E Hasselmo; Martin Sarter
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

8.  Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias.

Authors:  T Hershey; K J Black; M K Stambuk; J L Carl; L A McGee-Minnich; J S Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

9.  Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study.

Authors:  Pál Kocsis; István Gyertyán; János Éles; Judit Laszy; Nikolett Hegedűs; Dávid Gajári; Levente Deli; Zsófia Pozsgay; Szabolcs Dávid; Károly Tihanyi
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

10.  Pharmacological models in Alzheimer's disease research.

Authors:  C Gilles; S Ertlé
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.